I. Michl’s research while affiliated with Medical University of Vienna and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (11)


Abstract
  • Article
  • Full-text available

September 1991

·

1,637 Reads

·

7 Citations

I Strohscheer

·

·

C. Westphal

·

[...]

·

Peer Reviewed http://deepblue.lib.umich.edu/bitstream/2027.42/46912/1/277_2005_Article_BF02044602.pdf

Download

Citations (5)


... ICAM-1's production have been stimulated by tumor necrosis factor alpha (TNFα). This was not the case with colony stimulating factor (CSF), interleukins 2 and 6 (IL-2 and IL-6), and interferons alpha and gamma (IFNα and IFNγ) [21]. It was also reported that ICAM-1's production have been decreased in stomach cancer which is correlated to lymphatic metastasis [22]. ...

Reference:

Tumor microenvironment (Part I): Tissue integrity in a rat model of peripheral neural cancer
Decreased expression of ICAM‐1 and its induction by tumor necrosis factor on breast‐cancer cells in vitro
  • Citing Article
  • June 1997

... Other reports have stated that tumours propagated as a result of NK activity depression, and that metastasis could be inhibited by elevating NK activity [41±43]. There have also been a number of cases of metastatic-free survival extension in tumour patients with high NK activity [44,45]. Since the effects of immune surveillance and the antitumour activities of NK cells can affect tumour growth, it is possible that the NK cells activated by DCs possess potent antitumour activity, and may be applicable to the clinical treatment of cancer patients. ...

Natural killer cell activity in long term survivors of testicular cancer: Influence of cytostatic therapy and initial stage of disease
  • Citing Article
  • January 1995

Cancer

... Our findings are consistent with reports showing the presence of susceptibility loci within the HLA-gene region for coronary artery disease (CAD) [38] and inflammatory/autoimmune disorders [39]. Autoimmune features and rheumatic manifestations have been reported in cancer patients after chemotherapy [40] including rheumatism, and systemic lupus erythematosus (SLE) in those with breast cancer [41]. ...

More post chemotherapy rheumatism
  • Citing Article
  • November 1993

Journal of Clinical Oncology

... Jednym z poważnych powikłań u pacjentów operowanych z powodu raka piersi jest obrzęk limfatyczny. Zaobserwowano, że w tej grupie pacjentów agregacja czerwonych krwinek jest podwyższona [48]. Na podstawie przeprowadzonych badań lepkości osocza, agregacji erytrocytów i morfologii naczyń włosowatych oraz przepływów w grupie pacjentów z z rakiem piersi z obrzękiem i bez zapostulowano istnienie nieznanego białkowego czynnika sprzyjającego Anna Marcinkowska-Gapińska Zeszyty Naukowe WCO, Letters in Oncology Science 2019; 16(4): [162][163][164][165][166][167][168] agregacji erytrocytów i obrzękowi limfatycznemu [48]. ...

Impaired hemorheology in patients with postmastectomy lymphedema
  • Citing Article
  • February 1996

Breast Cancer Research and Treatment